Skip to main content

Advertisement

Log in

Smoking, health-related quality of life and economic evaluation

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Background and aims

The economic evaluation of tobacco control policies requires the adoption of assumptions about the impact of changes in smoking status on health-related quality of life (HRQoL). Estimates for such impacts are necessary for different populations. This paper aims to test whether smoking status has an independent effect on HRQoL over and above the effect derived from the increased likelihood of suffering a tobacco related disease, and to calculate utility values for the Spanish population.

Methods

Using data from the Spanish Encuesta Nacional de Salud of 2011–12, we estimate statistical models for HRQoL as measured by the EQ-5D-5L instrument as a function of smoking status. We include a comprehensive set of controls for biological, clinical, lifestyle and socioeconomic characteristics.

Results

Smoking status has an independent, statistically significant effect on HRQoL. However, the size of the effect is small. The typical smoking related diseases, such as lung cancer, are associated with a reduction in HRQoL about 5 times larger than the difference between current smokers and never smokers.

Conclusion

Attributing substantive HRQoL gains to quitting smoking as well as accounting for the concomitant HRQoL gain derived from a smaller likelihood of contracting tobacco related diseases might lead to an overestimation of the benefits of tobacco control policies. Nonetheless, the relatively large drops in HRQoL associated with being diagnosed with diseases that might be causally linked to tobacco suggest that such diseases should not be omitted from the economic evaluations of tobacco control policies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. The Short Form-36 (SF-36) questionnaire is an established and also widely used health-related quality of life measure (HRQoL) [19]. It comprises eight health domains including ‘physical functioning’ [19].

  2. The estimation of the second part of the model uses a smaller number of observations than the estimation for the first part. As reflected in Table 1, the sample sizes are 2770 for men and 5117 for women. However, these samples contain variation in smoking status: among males there are 952 never smokers, 796 current smokers and 1022 former smokers and among women the corresponding figures are 3729, 845 and 543.

References

  1. World Health Organization. WHO Global Report: Mortality attributable to tobacco. WHO. http://www.who.int/tobacco/publications/surveillance/rep_mortality_attributable/en/ (2012). Accessed 18 July 2016

  2. World Health Organization. Tobacco. Fact sheet 339. WHO. http://www.who.int/mediacentre/factsheets/fs339/en/ (2016). Accessed 18 July 2016

  3. US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta, GA (2014)

  4. Atusingwize, E., Lewis, S., Langley, T.: Economic evaluations of tobacco control mass media campaigns: a systematic review. Tob. Control 24, 320–327 (2015). doi:10.1136/tobaccocontrol-2014-051579

    Article  PubMed  Google Scholar 

  5. Kahende, J.W., Loomis, B.R., Adhikari, B., Marshall, L.: A review of economic evaluations of tobacco control programs. Int. J. Environ. Res. Public Health 6, 51–68 (2009). doi:10.3390/ijerph6010051

    Article  PubMed  Google Scholar 

  6. Weinstein, M.C., Torrance, G., McGuire, A.: QALYs: the basics. Value Health 12(1), S5–S9 (2009)

    Article  PubMed  Google Scholar 

  7. Vogl, M., Wenig, C.M., Leidl, R., Pokhrel, S.: Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 12, 203 (2012). doi:10.1186/1471-2458-12-203

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ramos-Goni, J.M., Pinto-Prades, J.L., Oppe, M., Cabases, J.M., Serrano-Aguilar, P., Rivero-Arias, O.: Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med. Care (2014). doi:10.1097/MLR.0000000000000283

    Google Scholar 

  9. Augustovski, F., Rey-Ares, L., Irazola, V., Garay, O.U., Gianneo, O., Fernandez, G., et al.: An EQ-5D-5L value set based on Uruguayan population preferences. Qual. Life Res. 25, 323–333 (2016). doi:10.1007/s11136-015-1086-4

    Article  PubMed  Google Scholar 

  10. EuroQol Group.: EQ-5D nomenclature. http://www.euroqol.org/about-eq-5d/eq-5d-nomenclature.html (2017). Accessed on May 2017

  11. Over, E.A., Feenstra, T.L., Hoogenveen, R.T., Droomers, M., Uiters, E., van Gelder, B.M.: Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness. Nicotine Tob. Res. 16, 725–732 (2014). doi:10.1093/ntr/ntt218

    Article  PubMed  Google Scholar 

  12. Howard, P., Knight, C., Boler, A., Baker, C.: Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers. Pharmacoeconomics 26, 497–511 (2008)

    Article  CAS  PubMed  Google Scholar 

  13. Stanczyk, N.E., Smit, E.S., Schulz, D.N., de Vries, H., Bolman, C., Muris, J.W., et al.: An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 9, e110117 (2014). doi:10.1371/journal.pone.011011

    Article  PubMed  PubMed Central  Google Scholar 

  14. de Fernandez, B.O.J., Sanchez-Maestre, C., Brosa Riestra, M., Arroyo, O., Sanz de Burgoa, V., Wilson, K.: Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain. Ann. Med. Intern. 25, 342–348 (2008). (in Spanish)

    Google Scholar 

  15. Becona, E., Vazquez, M.I., Miguez Mdel, C., Fernandez del Rio, E., Lopez-Duran, A., Martinez, U., et al.: Smoking habit profile and health-related quality of life. Psicothema 25, 421–426 (2013). doi:10.7334/psicothema2013.73

    PubMed  Google Scholar 

  16. Cayuela, A., Rodriguez-Dominguez, S., Otero, R.: Deteriorated health-related quality of life in healthy male smokers. Arch. Bronconeumol. 43, 59–63 (2007). (in Spanish)

    Article  PubMed  Google Scholar 

  17. Guiterrez-Bedmar, M., Segui-Gomez, M., Gomez-Gracia, E., Bes-Rastrollo, M., Martinez-Gonzalez, M.A.: Smoking status, changes in smoking status and health-related quality of life: findings from the SUN (“Seguimiento Universidad de Navarra”) cohort. Int. J. Environ. Res. Public Health 6, 310–320 (2009). doi:10.3390/ijerph6010310

    Article  PubMed  PubMed Central  Google Scholar 

  18. de Lossada, A., Rejas, J.: Health-related quality-of-life in the smoking general population of Spain: an approach from the National Health Survey. Semergen (2015). doi:10.1016/j.semerg.2015.09.003. (in Spanish)

    Google Scholar 

  19. Ware Jr., J.E., Gandek, B.: Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J. Clin. Epidemiol. 51, 903–912 (1998)

    Article  PubMed  Google Scholar 

  20. Instituto Nacional de Estadística. Encuesta Nacional de Salud 2011-12. INE. http://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176783&menu=resultados&idp=1254735573175 (2013). Accessed 19 July 2016

  21. Huang, I.C., Frangakis, C., Atkinson, M.J., Willke, R.J., Leite, W.L., Vogel, W.B., et al.: Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv. Res. 43, 327–339 (2008). doi:10.1111/j.1475-6773.2007.00745.x

    Article  PubMed  PubMed Central  Google Scholar 

  22. Brooks RG. 28 Years of the EuroQol Group: an overview. EuroQol Working Paper Series, 2015. EuroQol Group. file:///C:/Users/Marta%20Trapero/Downloads/EuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_02.pdf (2015). Accessed on May 2017

Download references

Acknowledgements

The authors are very grateful to Dr. Toni Mora for his invaluable help and support to finish this paper. This work was partially funded by the European Union’s FP7 programme (the EQUIPT Project; Grant agreement 602270) and partially by the Spanish Ministry of Economy and Competitiveness (MINECO) under the programme “Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, Plan Estatal de Investigación Científica Técnica y de Innovación 2013–2016”. Grant ECO2013-48217-C2-1 (http://invesfeps.ulpgc.es/en). The funders had no influence on the conduction of this study or the drafting of this manuscript. We are grateful for the comments and suggestions of the editor of this journal and two anonymous referees. The usual disclaimer applies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ángel López-Nicolás.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

López-Nicolás, Á., Trapero-Bertran, M. & Muñoz, C. Smoking, health-related quality of life and economic evaluation. Eur J Health Econ 19, 747–756 (2018). https://doi.org/10.1007/s10198-017-0919-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-017-0919-1

Keywords

JEL Classfication

Navigation